Transfusion. 1990 Jun;30(5):441-3.

Factor IX concentrate versus prothrombin complex concentrate for the treatment of hemophilia B during surgery.

Source

Centre d'Accueil et de Traitement des Hémophiles, Hôpital Cochin, Paris, France.

Abstract

Hemophilia B patients are usually treated for the prevention and control of bleeding episodes with a plasma derivative containing the four vitamin K-dependent clotting factors (PPSB). Prothrombin complex concentrate and the French PPSB concentrate are known to be thrombogenic when used in long-term treatment of surgical patients. The present study reports two cases of thrombotic episodes following surgery in PPSB-treated hemophilia B patients. Since 1986, there has been available a factor IX (FIX) concentrate depleted of the other vitamin K-dependent clotting factors and virally inactivated by the solvent-detergent method. This preparation has been used as replacement therapy in six patients with severe hemophilia B who were to undergo orthopedic surgery. The management of the patients before and after operation was without any thrombotic complication or undesirable side effects. The present study suggests that there is a need for an FIX preparation devoid of the other vitamin K-dependent clotting factors for long-term therapy of hemophilia B patients.

PMID:: 2360238; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

LinkOut - more resources

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentrates. [Blood. 1992]
Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentrates.
Kim HC, McMillan CW, White GC, Bergman GE, Horton MW, Saidi P. Blood. 1992 Feb 1; 79(3):568-75.
Clinical experience of a new monoclonal antibody purified factor IX: half-life, recovery, and safety in patients with hemophilia B. [Semin Hematol. 1990]
Clinical experience of a new monoclonal antibody purified factor IX: half-life, recovery, and safety in patients with hemophilia B.
Kim HC, McMillan CW, White GC, Bergman GE, Saidi P. Semin Hematol. 1990 Apr; 27(2 Suppl 2):30-5.
Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate. [Blood. 1990]
Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate.
Mannucci PM, Bauer KA, Gringeri A, Barzegar S, Bottasso B, Simoni L, Rosenberg RD. Blood. 1990 Dec 15; 76(12):2540-5.
Review Update on treatment regimens: prophylaxis versus on-demand therapy. [Semin Hematol. 2003]
Review Update on treatment regimens: prophylaxis versus on-demand therapy.
Manco-Johnson MJ. Semin Hematol. 2003 Jul; 40(3 Suppl 3):3-9.
Review Myocardial infarction during factor IX infusion in hemophilia B: case report and review of the literature. [Ann Hematol. 2004]
Review Myocardial infarction during factor IX infusion in hemophilia B: case report and review of the literature.
Najaf SM, Malik A, Quraishi AU, Kazmi K, Kakepoto GN. Ann Hematol. 2004 Sep; 83(9):604-7. Epub 2004 Jun 16.

See reviews... See all...

Cited by 1 PubMed Central article

Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital. [Crit Care. 2008]
Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital.
Bruce D, Nokes TJ. Crit Care. 2008; 12(4):R105. Epub 2008 Aug 15.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Factor IX concentrate versus prothrombin complex concentrate for the treatment o...
Factor IX concentrate versus prothrombin complex concentrate for the treatment of hemophilia B during surgery.
Transfusion. 1990 Jun ;30(5):441-3.

PubMed
The contribution of the kidney to the removal of a lactic acid load under normal...
The contribution of the kidney to the removal of a lactic acid load under normal and acidotic conditions in the conscious rat.
Clin Sci Mol Med. 1975 Feb ;48(2):121-31.

PubMed
The acute splanchnic and peripheral tissue metabolic response to endotoxin in hu...
The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans.
J Clin Invest. 1990 Jun ;85(6):1896-904.

PubMed
Comparison of the cardiopulmonary effects of subcutaneously administered epineph...
Comparison of the cardiopulmonary effects of subcutaneously administered epinephrine and terbutaline in patients with reversible airway obstruction.
Chest. 1975 Mar ;67(3):279-86.

PubMed
The prominent role of thromboxane A2 formation on early pulmonary hypertension i...
The prominent role of thromboxane A2 formation on early pulmonary hypertension induced by oleic acid administration in sheep.
Thromb Res. 1990 Apr 1 ;58(1):35-45.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: